| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/20/2002 | DE10061232A1 Verfahren zur Gewinnung und Aufbereitung von Laist für medizinische Anwendungen, insbesondere zur Behandlung von Hautkrankheiten A method for extraction and preparation of Laist for medicinal applications, in particular for the treatment of skin diseases |
| 06/20/2002 | CA2436830A1 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 06/20/2002 | CA2431852A1 Herbal pharmaceutical compositions for treating immunological disorders |
| 06/20/2002 | CA2431406A1 Quinazolinone derivatives |
| 06/20/2002 | CA2431107A1 Antitumoral carbazoles |
| 06/20/2002 | CA2428216A1 Secreted proteins |
| 06/19/2002 | EP1215214A1 Novel polypeptide |
| 06/19/2002 | EP1215203A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 06/19/2002 | EP1214941A1 Composition for treating extensive and open wounds |
| 06/19/2002 | EP1214937A2 Terfenadine carboxylate and the treatment of dermal irritation |
| 06/19/2002 | EP1214933A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 06/19/2002 | EP1214929A2 Use of polyurethanes for increasing the water-resistance of cosmetic or dermatological formulations |
| 06/19/2002 | EP1214927A1 Use of folic acid and/or its derivatives for the manufacture of topical compositions |
| 06/19/2002 | EP1214926A1 Topical composition |
| 06/19/2002 | EP1214925A1 Chemical peeling agent |
| 06/19/2002 | EP1214443A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 06/19/2002 | EP1214440A2 Sequence-specific dna recombination in eukaryotic cells |
| 06/19/2002 | EP1214422A1 Phosphatases which activate map kinase pathways |
| 06/19/2002 | EP1214409A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 06/19/2002 | EP1214404A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 06/19/2002 | EP1214401A2 Dna encoding the human serine protease c-e |
| 06/19/2002 | EP1214400A2 Zymogen activation system |
| 06/19/2002 | EP1214398A2 Chimeric virus-like particles or chimeric capsomers from bpv |
| 06/19/2002 | EP1214396A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 06/19/2002 | EP1214347A2 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| 06/19/2002 | EP1214346A1 A novel angiogenesis inhibitor |
| 06/19/2002 | EP1214345A2 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth |
| 06/19/2002 | EP1214337A2 Proteins associated with cell differentiation |
| 06/19/2002 | EP1214325A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/19/2002 | EP1214324A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/19/2002 | EP1214318A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 06/19/2002 | EP1214303A1 Heterocyclic compounds and methods of use thereof |
| 06/19/2002 | EP1214293A1 Non-peptidic cyclophilin binding compounds and their use |
| 06/19/2002 | EP1214292A1 Tyrosine derivatives |
| 06/19/2002 | EP1214090A2 Novel uses of mammalian ccr6 receptors and related reagents |
| 06/19/2002 | EP1214089A1 Therapeutic uses of m3 polypeptide |
| 06/19/2002 | EP1214081A2 Superoxidized water based on hypochlorous acid for the treatment of wounds |
| 06/19/2002 | EP1214071A2 Treating allergic and inflammatory conditions using desloratadine |
| 06/19/2002 | EP1214064A1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 06/19/2002 | EP1214051A1 Use of a vegetable oil product as agent for increasing skin lipid synthesis |
| 06/19/2002 | EP1214050A1 Skin-balance moisturizing cream |
| 06/19/2002 | EP1214048A1 Use of conjugated linoleic acid (cla) for the topical treatment of cellulite |
| 06/19/2002 | EP1213975A2 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds, and therapeutic, cosmetical or food use of said compounds |
| 06/19/2002 | EP0941054B1 Use of sterolsulfates as active substances for producing means to inhibit serin proteases |
| 06/19/2002 | EP0877619B1 Use of ginkgo biloba extracts for the preparation of pharmaceutical compositions |
| 06/19/2002 | CN1354798A Process for preparation of pseudomonic acid A antibiotic by microbiological method |
| 06/19/2002 | CN1354672A Composition comprising alkaline sphingomyelinase for use as dietetic preparation, food supplement or pharmaceutical product |
| 06/19/2002 | CN1354670A Therapeutic agent comprising botulinum neurotoxin |
| 06/19/2002 | CN1354640A Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 06/19/2002 | CN1354009A Prescription of medicine for curing pointed condyloma |
| 06/19/2002 | CN1354006A Infantile prickly-heat powder |
| 06/19/2002 | CN1354005A Medicine for curing tinea manuum and tinea pedis and preparing method thereof |
| 06/19/2002 | CN1354001A Prescription of medicine for curing heloma and planter wart |
| 06/19/2002 | CN1353999A Baifengyin oral liquor prescription and its preparation process |
| 06/19/2002 | CN1353997A Chinese herbal medicine foot effervescent tablets |
| 06/19/2002 | CN1353995A Preparation method of oily medicine for curing burn |
| 06/19/2002 | CN1353993A Compounded medicine for curing dermatophytid infection |
| 06/19/2002 | CN1086298C Ointment for rheumatic spur |
| 06/19/2002 | CN1086290C Composition for treating condyloma acuminata |
| 06/18/2002 | US6407250 Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists |
| 06/18/2002 | US6407114 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 06/18/2002 | US6407108 1,2,4-triazolo(4,3-b)pyrido(3,2-d)pyridazine derivatives and pharmaceutical compositions containing them |
| 06/18/2002 | US6407104 Pyrrolo[1,2-a]pyrazine spla2 inhibitor |
| 06/18/2002 | US6407084 Cosmetic or dermatological use of 7-hydroxylated steroids |
| 06/18/2002 | US6406897 Modified protein with improved stability coupled to glycan |
| 06/18/2002 | US6406720 Cosmetic containing plant extracts |
| 06/18/2002 | US6406708 Therapeutic compositions |
| 06/18/2002 | US6406707 Method for treatment of psoriasis |
| 06/14/2002 | CA2350347A1 Cosmetic composition |
| 06/13/2002 | WO2002046749A2 Screening method for identifying compounds that selectively induce interferon alpha |
| 06/13/2002 | WO2002046475A2 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 06/13/2002 | WO2002046412A2 Regulation of angiogenesis with zinc finger proteins |
| 06/13/2002 | WO2002046409A2 Proteins and nucleic acids encoding same |
| 06/13/2002 | WO2002046389A2 Genes associated with allergic hypersensitivity and mast cell activation |
| 06/13/2002 | WO2002046384A2 Kinases and phosphatases sequences, and use thereof |
| 06/13/2002 | WO2002046383A2 Protein modification and maintenance molecules |
| 06/13/2002 | WO2002046373A1 Method of collecting placental stem cells |
| 06/13/2002 | WO2002046240A1 Multicomponent compositions containing chitosan and methods of preparing same |
| 06/13/2002 | WO2002046214A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2002 | WO2002046197A1 Macroheterocylic compounds useful as kinase inhibitors |
| 06/13/2002 | WO2002046193A2 Heterocyclic ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046192A2 Thioether substituted imidazoquinolines |
| 06/13/2002 | WO2002046191A2 Urea substituted imidazoquinoline ethers |
| 06/13/2002 | WO2002046190A2 Sulfonamido ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046189A2 Aryl ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046188A2 Amido ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046186A1 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
| 06/13/2002 | WO2002046184A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 06/13/2002 | WO2002046183A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 06/13/2002 | WO2002046182A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors |
| 06/13/2002 | WO2002046171A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 06/13/2002 | WO2002046170A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 06/13/2002 | WO2002046167A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands |
| 06/13/2002 | WO2002046158A2 Piperidine/piperazine-type inhibitors of p38 kinase |
| 06/13/2002 | WO2002046147A2 Perturbed membrane-binding compounds |
| 06/13/2002 | WO2002045800A2 Liquid composition comprising an alcohol |
| 06/13/2002 | WO2002045752A2 Dermal anti-inflammatory composition |
| 06/13/2002 | WO2002045740A1 Compositions containing gangliosides for use in the treatment of skin disorders |
| 06/13/2002 | WO2002045737A2 Methods of treatment involving human mda-7 |
| 06/13/2002 | WO2002045733A2 Oral preprations having itching-relievign or antipruritic activity |